Cargando…
Is fibrinogen the answer to coagulopathy after massive transfusions?
Coagulopathy is a major cause of morbidity and mortality in patients who have suffered severe hemorrhage and received massive transfusions. Administration of a fibrinogen concentrate along with red blood cells can quickly restore hemostasis in a clinically relevant animal model.
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911703/ https://www.ncbi.nlm.nih.gov/pubmed/20497599 http://dx.doi.org/10.1186/cc9000 |
| _version_ | 1782184500262862848 |
|---|---|
| author | Tisherman, Samuel A |
| author_facet | Tisherman, Samuel A |
| author_sort | Tisherman, Samuel A |
| collection | PubMed |
| description | Coagulopathy is a major cause of morbidity and mortality in patients who have suffered severe hemorrhage and received massive transfusions. Administration of a fibrinogen concentrate along with red blood cells can quickly restore hemostasis in a clinically relevant animal model. |
| format | Text |
| id | pubmed-2911703 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-29117032011-05-14 Is fibrinogen the answer to coagulopathy after massive transfusions? Tisherman, Samuel A Crit Care Commentary Coagulopathy is a major cause of morbidity and mortality in patients who have suffered severe hemorrhage and received massive transfusions. Administration of a fibrinogen concentrate along with red blood cells can quickly restore hemostasis in a clinically relevant animal model. BioMed Central 2010 2010-05-14 /pmc/articles/PMC2911703/ /pubmed/20497599 http://dx.doi.org/10.1186/cc9000 Text en Copyright ©2010 BioMed Central Ltd |
| spellingShingle | Commentary Tisherman, Samuel A Is fibrinogen the answer to coagulopathy after massive transfusions? |
| title | Is fibrinogen the answer to coagulopathy after massive transfusions? |
| title_full | Is fibrinogen the answer to coagulopathy after massive transfusions? |
| title_fullStr | Is fibrinogen the answer to coagulopathy after massive transfusions? |
| title_full_unstemmed | Is fibrinogen the answer to coagulopathy after massive transfusions? |
| title_short | Is fibrinogen the answer to coagulopathy after massive transfusions? |
| title_sort | is fibrinogen the answer to coagulopathy after massive transfusions? |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911703/ https://www.ncbi.nlm.nih.gov/pubmed/20497599 http://dx.doi.org/10.1186/cc9000 |
| work_keys_str_mv | AT tishermansamuela isfibrinogentheanswertocoagulopathyaftermassivetransfusions |